We are live on
!
Find out more
Pacer Advisors Portfolio holdings
AUM
$35.6B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
+6.36%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$5.75B
AUM Growth
+$430M
(+8.1%)
Cap. Flow
-$1.1B
Cap. Flow
% of AUM
-19.08%
Top 10 Holdings %
Top 10 Hldgs %
27.15%
Holding
1,587
New
76
Increased
378
Reduced
937
Closed
183
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$6.27M |
| 2 |
TJX Companies
TJX
|
+$5.89M |
| 3 |
General Mills
GIS
|
+$5.87M |
| 4 |
HP
HPQ
|
+$5.84M |
| 5 |
Ford
F
|
+$5.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$16.7M |
| 2 |
Amazon
AMZN
|
+$14.9M |
| 3 |
Iron Mountain
IRM
|
+$14.6M |
| 4 |
Microsoft
MSFT
|
+$12.9M |
| 5 |
GDS Holdings
GDS
|
+$9.75M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 17.47% |
| 2 | Technology | 14.6% |
| 3 | Consumer Discretionary | 9.29% |
| 4 | Healthcare | 7.36% |
| 5 | Communication Services | 6.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
ImmunityBio
IBRX
$7.3B
| $38K | ﹤0.01% |
+1,618
| New | +$41.9K |
|
1327
Sibanye-Stillwater
SBSW
$5.93B
| $38K | ﹤0.01% |
2,119
+846
| +66% | +$14.9K |
|
1328
Passage Bio
PASG
$14.7M
| $37K | ﹤0.01% |
+106
| New | +$45.3K |
|
|
MANT
1329
DELISTED
Mantech International Corp
MANT
| $36K | ﹤0.01% |
410
+15
| +4% | +$1.31K |
|
|
PBFX
1330
DELISTED
PBF LOGISTICS LP
PBFX
| $35K | ﹤0.01% |
2,395
+9
| +0.4% | +$105 |
|
1331
Gerdau
GGB
$9.72B
| $31K | ﹤0.01% |
7,334
+2,797
| +62% | +$10.6K |
|
1332
Kornit Digital
KRNT
$708M
| $31K | ﹤0.01% |
310
-15
| -5% | -$1.48K |
|
|
RNAM
1333
DELISTED
Avidity Biosciences
RNAM
| $31K | ﹤0.01% |
1,417
+578
| +69% | +$14.2K |
|
1334
Stoke Therapeutics
STOK
$1.83B
| $31K | ﹤0.01% |
811
+384
| +90% | +$21.9K |
|
1335
V2X
VVX
$2.82B
| $31K | ﹤0.01% |
587
-54
| -8% | -$2.96K |
|
|
AKRO
1336
DELISTED
Akero Therapeutics
AKRO
| $30K | ﹤0.01% |
1,034
-216
| -17% | -$6.54K |
|
|
BRFS
1337
DELISTED
BRF SA
BRFS
| $29K | ﹤0.01% |
6,348
+2,436
| +62% | +$10.2K |
|
1338
CytomX Therapeutics
CTMX
$701M
| $29K | ﹤0.01% |
3,806
+1,000
| +36% | +$7.92K |
|
1339
Fiverr
FVRR
$417M
| $29K | ﹤0.01% |
135
-5
| -4% | -$1.23K |
|
1340
Geron
GERN
$930M
| $29K | ﹤0.01% |
18,114
+3,236
| +22% | +$5.78K |
|
1341
Praxis Precision Medicines
PRAX
$8.25B
| $29K | ﹤0.01% |
+58
| New | +$41.2K |
|
|
TECX
1342
Tectonic Therapeutic
TECX
$562M
| $29K | ﹤0.01% |
193
+93
| +93% | +$15.1K |
|
|
CMRX
1343
DELISTED
Chimerix, Inc.
CMRX
| $29K | ﹤0.01% |
+2,996
| New | +$27.5K |
|
1344
Kiniksa Pharmaceuticals
KNSA
$6.11B
| $28K | ﹤0.01% |
1,503
-870
| -37% | -$17.8K |
|
1345
Puma Biotechnology
PBYI
$406M
| $28K | ﹤0.01% |
2,837
-598
| -17% | -$6.68K |
|
1346
TIM SA
TIMB
$9.45B
| $28K | ﹤0.01% |
2,491
+950
| +62% | +$11.6K |
|
1347
Anika Therapeutics
ANIK
$202M
| $26K | ﹤0.01% |
645
+40
| +7% | +$1.52K |
|
1348
Ardelyx
ARDX
$1.25B
| $26K | ﹤0.01% |
3,896
+1,562
| +67% | +$10.7K |
|
1349
Arcutis Biotherapeutics
ARQT
$3.55B
| $26K | ﹤0.01% |
887
-184
| -17% | -$5.75K |
|
|
ATHX
1350
DELISTED
Athersys, Inc. Common Stock
ATHX
| $26K | ﹤0.01% |
576
+70
| +14% | +$3.63K |
|
Similar funds
SAM
Pacer Advisors's Q1 2021 Portfolio in Review
As of Q1 2021, Pacer Advisors held 1,587 positions worth $5.75B, up 8.1% from $5.32B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Pacer Advisors withdrew a net $1.1B in Q1 2021, closing 183 positions and reducing 937 holdings. Its most notable exit was Rithm Capital, an estimated $4.39M position sold in full.
By sector, the portfolio is most concentrated in Real Estate at 17% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Pacer Advisors opened a new position in Aerojet Rocketdyne Holdings worth $3.39M.
- Pacer Advisors's largest Q1 2021 buy was Aerojet Rocketdyne Holdings: 72,150 shares worth $3.39M.
- Pacer Advisors added most to Newmont in Q1 2021, an estimated $6.27M increase.
- Pacer Advisors's biggest Q1 2021 reduction was Apple, cutting an estimated $16.7M.
- Pacer Advisors fully exited Rithm Capital in Q1 2021, selling an estimated $4.39M.
- Pacer Advisors's ten largest holdings make up 27% of its $5.75B portfolio in Q1 2021.
- Pacer Advisors opened 76 new positions and closed 183 in Q1 2021.
- Pacer Advisors's portfolio value rose 8.1% quarter-over-quarter to $5.75B.
Based on Pacer Advisors's 13F filing for Q1 2021, filed 5 Apr 2021.